Krystal Biotech (KRYS) EBT Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 32.79% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 47.54% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -49.71% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 12.01% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 20.92% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -1.05% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 48.67% |
| 10 | Krystal Biotech | 9.05 Bn | 8.23 Bn | 110.03 Mn | 49.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.72% |
| Dec 31, 2025 | 53.19% |
| Sep 30, 2025 | 53.36% |
| Jun 30, 2025 | 54.17% |
| Mar 31, 2025 | 42.15% |
| Dec 31, 2024 | 61.72% |
| Sep 30, 2024 | 57.54% |
| Jun 30, 2024 | 43.91% |
| Mar 31, 2024 | 27.22% |
| Dec 31, 2023 | 44.65% |
| Sep 30, 2023 | 118.30% |
| Jun 30, 2023 | -69.39% |
| Mar 31, 2023 | -103.93% |
| Dec 31, 2022 | -81.54% |
| Sep 30, 2022 | -91.18% |
| Jun 30, 2022 | -73.87% |
| Mar 31, 2022 | -129.92% |
| Dec 31, 2021 | -80.50% |
| Sep 30, 2021 | -78.20% |
| Jun 30, 2021 | -93.00% |
| Mar 31, 2021 | -94.47% |
| Dec 31, 2020 | -95.34% |
| Sep 30, 2020 | -22.15% |
| Jun 30, 2020 | -108.03% |
| Mar 31, 2020 | -121.12% |
| Dec 31, 2019 | -105.20% |
| Sep 30, 2019 | -136.73% |